Table 2

 Immediate and delayed adverse events by patient (n = 58) and by infusion (n = 345)

Adverse eventPatients with adverse events (%)*Infusions with adverse events (%)*
OverallImmediateDelayedOverallImmediateDelayed
*Percentages given are for patients and infusions with follow up.
Headache15 (25.9)3 (5.2)14 (24.1)47 (13.7)3 (0.9)44 (12.8)
Fatigue12 (20.0)012 (20.7)18 (5.2)018 (5.2)
Abdominal pain8 (13.8)08 (13.8)8 (2.3)08 (2.3)
Myalgia4 (6.7)04 (6.7)8 (2.3)08 (2.3)
Nausea4 (6.7)1 (1.7)3 (5.2)4 (1.2)1 (0.3)3 (0.9)
Fever4 (6.7)1 (1.7)3 (5.2)4 (1.2)1 (0.3)3 (0.9)
Rash4 (6.7)1 (1.7)2 (3.4)9 (2.6)1 (0.3)8 (2.3)
Pain at infusion site2 (3.4)2 (3.4)03 (0.9)3 (0.9)0
Vertigo2 (3.4)2 (3.4)03 (0.9)3 (0.9)0
Arthralgia2 (3.4)02 (3.4)2 (0.6)02 (0.6)
Palpitation1 (1.7)1 (1.7)02 (0.6)2 (0.6)0
Bronchospasm1 (1.7)1 (1.7)02 (0.6)2 (0.6)0
Plantar fasciitis1 (1.7)01 (1.7)1 (0.3)01 (0.3)
Chest pain1 (1.7)1 (1.7)01 (0.3)1 (0.3)0
Overall1121795